Inactive Instrument

Chelsea Therapeutics International Ltd. Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

14-06-12	Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders	GL
14-05-09	Chelsea Therapeutics : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S	BU
14-05-09	Chelsea Therapeutics : Newman Ferrara LLP : Announces Investigation of Chelsea Therapeutics International Ltd.	BU
14-05-08	Chelsea Therapeutics : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders	BU
14-05-08	Chelsea Therapeutics : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S	BU

14-05-08

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+1.52%	-7.16%	+51.66%	+67.41%	65B
LONZA GROUP AG	+1.23%	+6.20%	+10.24%	+78.25%	51.2B
ARGENX SE	+0.63%	-0.11%	+0.33%	+62.47%	51.19B
IQVIA HOLDINGS INC.	-0.68%	+1.12%	+25.03%	+41.97%	43.93B
BEONE MEDICINES AG	+0.20%	+5.51%	+16.04%	+133.00%	41.96B
REVOLUTION MEDICINES, INC.	+1.84%	-6.90%	+234.31%	+522.62%	38.14B
CELLTRION, INC.	+2.16%	+10.36%	+18.92%	+59.70%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.49%	+37.09%	+1.80%	25.2B
GENMAB A/S	+1.60%	+2.21%	+27.96%	+28.00%	22.5B
Average	+0.82%	+0.14%	+46.84%	+110.58%	41.37B
Weighted average by Cap.	+0.86%	+0.04%	+45.12%	+111.73%